Member Info for Dougie999

Looking at the chart of venturex right now is insane - 8% up again right now

Thanks Heimdel , can you explain the significance or reasoning for the amortization? I have read up on it but can’t comprehend it’s purposes fully, is it along the lines of a mortgage where the cost is spread out over time ? But I sense there are important differences that I could not gather from my reading

Great to see venturex powering ahead , no idea how long company plan to hold but copper market very buoyant- only a good thing for us .
Does anyone have a clue how long we should have to wait for the fda results in June or July ? Will we be told an outcome of p2 or just that results are either good or bad looking ?
Thanks again all

I appreciate the in depth analysis and thoughts Alq, even if they go against what LTH's would ever want. It is a medically researched fact that PE is one the most common problems in that area of health, so I have to disagree that there may not be demand but Fortacin must be shown/proved to be the lead treatment for people to use.

In regards to EU, you have a much better understanding than me of the processes involved so i can't comment too much, my thought is that Fortacin is not a very visible product that people would know about right now, and maybe that could change with more brand awareness from the holy grail us approval , and the boost in coverage if that was achieved from news outlets. This could result in a big increase maybe even outside the us.

If what you say is correct and maybe it is or it is not, I do not understand why the company would have persisted for so long , I believe they must have a very good understanding of the potential.

with regards to DLI I have no understanding apart from the fact that medical area is growing , and Venturex is a surprise that no shareholder would complain about even if it goes against the company's stated philosophy, because it has added some serious value at this stage.

Alq you seem to have a lot of knowledge in the area so appreciate your thoughts , even if could be viewed negatively you raise points . What are your thoughts for how this will play out ? Are you a holder here ?

Yes good points regarding venturex being a legacy holding...but if it’s boosting our market cap then it’s a good thing and can’t be viewed as a negative .

With regards to USA , if the results are good ,will there be more hoops to jump through before a potential partner may get involved ? Surely over all the years they have done their due diligence already on the capabilities of the product and it’s potential worth to them, if it can gain approval for use.

Can anyone explain the “locked in” phrase in the announcement regarding the USA results ? Don’t know what this signifies .

Heimdel I love the positivity! I seriously hope you are right , I keep belief from the fact staff have a track record of some successful deals and hopefully they can produce something special here even when hope is dwindling along for many years . I have read announcements for years and always stated USA partners is in discussion, I can only assume companies must have to wait for results from trials to get involved . Look at what venturex as done out of the blue , hopefully fortacin and deep longevity can follow suit !!

Bignose , you raise a lot of good valid points . I was looking at it in the sense of they have detailed moving forward regarding USA etc but nothing substantial in reality , I agree I found it strange venturex was featured first ... also deep longevity I still don’t know have a clue regarding game plan with it

Have to say I was expecting a bigger positive price reaction today due to updates I must give up from trying to predict how this market will react to news !!

this is no doubt positive announcement. fda signs look good, venturex value increase is mentioned. america has and always will be the main market by a long way and this update seems to signify progress.

Have they issued a date on when to expect this or is it just anytime during may ? Hopefully venturex has been played well and either we still are involved, or have profited significantly .
A great driver from now would be some impactful updates regarding fortacin , we all have known for a long time the value of us market so positive updates would be significant ! In regards to deep longevity , I still don’t understand too much about it and potential demand for it but it could be a nice surprise and prove to be an excellent addition . Summarising I feel this price range could be left behind very quickly with a flurry of impressive announcements

Hi heimdel what do you mean about a block trade between $2-3 ? Not sure what you mean due to vxr not being anywhere near that price

Yeh this all makes a lot of sense . It seems to be vary hard to actually put a solid value on fortacin at the present time , I’ve followed intently for years and still don’t really have a clear picture as the market awareness stems from a few presentations over the many years and the numerous announcements regarding licenses, we have no real idea how it is viewed by key market players . Frustrating because I’ve been a big believer for a long time in the potential, especially when compared to Viagras historic sales yet since I gained interest it’s generally been all downhill . I hope the company manage to run venturex as I have not invested myself, and just allowed the exposure that we have . Regent does to be quite unique in the sense of one day news can be announced out of the blue and you wake up to a massive spike in volume and price and it seems this corresponds with the recent posts from bignose and Italian . Thanks all for your thoughts , greatly appreciated to hear some very valid points

Thanks for this input . How can that be possible when you look at market updates and progress since then? I understand there have been hiccups but it can’t be denied that the company are further ahead than back then .

Taking venturex into consideration against the current market cap and assuming regent still
hold ... it leaves us at £35 mil . If fortacin is viewed by usa to have any sort of potential surely this is seen as an absolute steal of a price .. not to mention asia market is moving ahead . If the pieces can fall into place at long last, a lot of growth can come quickly

The way we have held around the 0.18-0.2 range makes me think if we get some unexpectedly positive updates this could really motor, the way it moves on small volume suggests when the market takes serious interest the gains will come quickly

Thanks for your input heimdel as you have a greater insight than most here in regards to the fine details. Are we thinking fda progress should be satisfactory? Hopefully previous experience in this area can lead to a good outcome for us . The venturex holding is very interesting. As for deep longevity, who knows how it will play out ..

We still don’t know a real accurate valuation of leap so it’s hard to assume right now but hopefully

The thing that confuses me is it the company want to change the name to suit the longevity direction yet the big proportion of our value comes from fortacin and not an app which has paper value under 3 million?

Have the company definitely not sold their vxr holding yet ? The reason I check is maybe they would just wait till next update to tell us rather than release update if they had sold . Hopefully not by the look of it !!